Annual Operating Expenses
$177.38 M
+$127.03 M+252.34%
December 1, 2024
Summary
- As of March 10, 2025, CDTX annual total operating expenses is $177.38 million, with the most recent change of +$127.03 million (+252.34%) on December 1, 2024.
- During the last 3 years, CDTX annual operating expenses has risen by +$85.55 million (+93.16%).
- CDTX annual operating expenses is now at all-time high.
Performance
CDTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$54.18 M
+$36.79 M+211.50%
December 1, 2024
Summary
- As of March 10, 2025, CDTX quarterly total operating expenses is $54.18 million, with the most recent change of +$36.79 million (+211.50%) on December 1, 2024.
- Over the past year, CDTX quarterly operating expenses has stayed the same.
- CDTX quarterly operating expenses is now at all-time high.
Performance
CDTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CDTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +252.3% | 0.0% |
| 3 y3 years | +93.2% | +132.3% |
| 5 y5 years | +183.2% | +132.3% |
CDTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +252.3% | at high | +375.2% |
| 5 y | 5-year | at high | +252.3% | at high | +375.2% |
| alltime | all time | at high | >+9999.0% | at high | +9592.7% |
Cidara Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $177.38 M(+252.3%) | $54.18 M(+211.5%) |
| Sep 2024 | - | $17.39 M(+52.5%) |
| Jun 2024 | - | $11.40 M(-35.2%) |
| Mar 2024 | - | $17.59 M(+53.5%) |
| Dec 2023 | $50.34 M(-48.6%) | $11.46 M(-16.3%) |
| Sep 2023 | - | $13.69 M(+15.6%) |
| Jun 2023 | - | $11.84 M(-49.2%) |
| Mar 2023 | - | $23.33 M(-15.0%) |
| Dec 2022 | $97.95 M(+6.7%) | $27.43 M(+6.2%) |
| Sep 2022 | - | $25.82 M(+33.6%) |
| Jun 2022 | - | $19.33 M(-23.8%) |
| Mar 2022 | - | $25.37 M(+5.7%) |
| Dec 2021 | $91.83 M(+9.4%) | $24.00 M(-4.4%) |
| Sep 2021 | - | $25.11 M(+13.7%) |
| Jun 2021 | - | $22.09 M(+7.1%) |
| Mar 2021 | - | $20.63 M(-18.4%) |
| Dec 2020 | $83.92 M(+34.0%) | $25.28 M(+26.7%) |
| Sep 2020 | - | $19.95 M(-7.7%) |
| Jun 2020 | - | $21.60 M(+26.4%) |
| Mar 2020 | - | $17.09 M(+7.5%) |
| Dec 2019 | $62.64 M | $15.89 M(-1.1%) |
| Sep 2019 | - | $16.07 M(+12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $14.27 M(-13.0%) |
| Mar 2019 | - | $16.40 M(-1.2%) |
| Dec 2018 | $63.28 M(+13.6%) | $16.60 M(+12.7%) |
| Sep 2018 | - | $14.72 M(-2.8%) |
| Jun 2018 | - | $15.15 M(-9.9%) |
| Mar 2018 | - | $16.81 M(+24.9%) |
| Dec 2017 | $55.72 M(+15.0%) | $13.46 M(+9.9%) |
| Sep 2017 | - | $12.25 M(-26.3%) |
| Jun 2017 | - | $16.61 M(+24.0%) |
| Mar 2017 | - | $13.40 M(-6.7%) |
| Dec 2016 | $48.44 M(+49.9%) | $14.35 M(+16.4%) |
| Sep 2016 | - | $12.34 M(+4.0%) |
| Jun 2016 | - | $11.86 M(+20.0%) |
| Mar 2016 | - | $9.88 M(-0.4%) |
| Dec 2015 | $32.31 M(+222.6%) | $9.93 M(+7.8%) |
| Sep 2015 | - | $9.21 M(+42.8%) |
| Jun 2015 | - | $6.45 M(-4.2%) |
| Mar 2015 | - | $6.73 M(+44.8%) |
| Dec 2014 | $10.02 M(+825.7%) | $4.65 M(+40.0%) |
| Sep 2014 | - | $3.32 M(+123.1%) |
| Jun 2014 | - | $1.49 M(+166.2%) |
| Mar 2014 | - | $559.00 K |
| Dec 2013 | $1.08 M | - |
FAQ
- What is Cidara Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Cidara Therapeutics?
- What is Cidara Therapeutics annual operating expenses year-on-year change?
- What is Cidara Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly operating expenses year-on-year change?
What is Cidara Therapeutics annual total operating expenses?
The current annual operating expenses of CDTX is $177.38 M
What is the all time high annual operating expenses for Cidara Therapeutics?
Cidara Therapeutics all-time high annual total operating expenses is $177.38 M
What is Cidara Therapeutics annual operating expenses year-on-year change?
Over the past year, CDTX annual total operating expenses has changed by +$127.03 M (+252.34%)
What is Cidara Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CDTX is $54.18 M
What is the all time high quarterly operating expenses for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly total operating expenses is $54.18 M
What is Cidara Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CDTX quarterly total operating expenses has changed by $0.00 (0.00%)